Patents by Inventor Douglas Harrington

Douglas Harrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110040146
    Abstract: Disclosed herein is a device adapted for occluding the ovarian pathway of a female body for sterilization purposes. The device delivers RF energy to wound tissue at a desired location within at least one fallopian tube and implants a porous foam plug adjacent to the wounded tissue at said location. Depending on the plug's pore sizes, vascularized tissue may grow into the plug to prevent or discourage the formation of scar tissue around the plug and/or a vascularized capsule may form around the plug, which limits the patient's foreign body response so that the capsule does not constrict around the plug.
    Type: Application
    Filed: October 26, 2010
    Publication date: February 17, 2011
    Inventors: Douglas Harrington, Victoria E. Carr-Brendel, Brett S. Bownan
  • Patent number: 7660449
    Abstract: A method for measuring residual protein in a cellular specimen including obtaining a low magnification image of a candidate object of interest, filtering the candidate object of interest pixels with a low pass filter, morphologically processing the candidate object of interest pixels to identify artifact pixels, identifying the candidate object of interest by eliminating artifact pixels, acquiring a higher magnification image of the subsample for the candidate object of interest, transforming pixels of the higher magnification image in a first color space to a second color space to differentiate higher magnification candidate object of interest pixels from background pixels, identifying an object of interest from the candidate object of interest pixels in the second color space, and determining the optical density of the protein in a cell contained in a subsample, wherein the optical density is indicative of the residual component of a cellular protein.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: February 9, 2010
    Assignee: Carl Zeiss MicroImaging GmbH
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Publication number: 20080260233
    Abstract: A method for measuring residual protein in a cellular specimen including obtaining a low magnification image of a candidate object of interest, filtering the candidate object of interest pixels with a low pass filter, morphologically processing the candidate object of interest pixels to identify artifact pixels, identifying the candidate object of interest by eliminating artifact pixels, acquiring a higher magnification image of the subsample for the candidate object of interest, transforming pixels of the higher magnification image in a first color space to a second color space to differentiate higher magnification candidate object of interest pixels from background pixels, identifying an object of interest from the candidate object of interest pixels in the second color space, and determining the optical density of the protein in a cell contained in a subsample, wherein the optical density is indicative of the residual component of a cellular protein.
    Type: Application
    Filed: April 14, 2008
    Publication date: October 23, 2008
    Applicant: Carl Zeiss Microlmaging AIS, Inc.
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Patent number: 7359536
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with ?-naphthol butyrate with or without fluoride.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: April 15, 2008
    Assignee: Carl Zeiss MicroImaging AIS, Inc.
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Publication number: 20070215163
    Abstract: A device for sterilizing females by occluding the uterotubal junction. The device includes a catheter with a releasable heat generating plug which is used to thermally damage the uterotubal junction and cause it to constrict around the plug, after which the plug is released from the catheter and left in place in the uterotubal junction.
    Type: Application
    Filed: May 22, 2007
    Publication date: September 20, 2007
    Inventors: Douglas Harrington, Brett Bowman, Peter Breining
  • Publication number: 20060089658
    Abstract: A method and device for creating amenorrhea in women. A porous biomaterial implant is positioned into the ablated uterine cavity of a female patient. Once positioned in the uterine cavity, the porous biomaterial implant expands into its preformed shape or is inflated within the uterine cavity. The ablated uterine tissue then grows within the porous implant. Prior to insertion of the implant, the uterine cavity is prepared by performing endometrial ablation to at least the inferior or lower portion of the uterine cavity. Placement of the porous biomaterial causes the uterine cavity walls to coapt, achieving complete occlusion of the uterine cavity and prevention of endometrial regrowth.
    Type: Application
    Filed: October 21, 2004
    Publication date: April 27, 2006
    Inventor: Douglas Harrington
  • Publication number: 20050033281
    Abstract: A system for facilitating the placement of a catheter within the human body, in a lumen or vessel such as the fallopian tubes, and controlling the catheter after placement. The system coordinates the operation of treatment electrodes on the catheter with informative displays and prompts to an operator, based on information derived from electrical parameters of position detection electrodes on the catheter.
    Type: Application
    Filed: August 24, 2004
    Publication date: February 10, 2005
    Inventors: Brett Bowman, Vijay Dhaka, Kenneth Kitlas, Douglas Harrington
  • Publication number: 20040120562
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with &agr;-naphthol butyrate with or without fluoride.
    Type: Application
    Filed: December 5, 2003
    Publication date: June 24, 2004
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Patent number: 6671393
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with &agr;-naphthol butyrate with or without fluoride.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: December 30, 2003
    Assignee: ChromaVision Medical Systems, Inc.
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Publication number: 20020176613
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with &agr;-naphthol butyrate with or without fluoride.
    Type: Application
    Filed: December 10, 2001
    Publication date: November 28, 2002
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Patent number: 6330349
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with &agr;-naphthol butyrate with or without fluoride.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: December 11, 2001
    Assignee: ChromaVision Medical Systems, Inc.
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Patent number: 5890308
    Abstract: A graphic material display device having a baseball bat-like shape. A centrally located shoulder and a second shoulder located adjacent one of the ends are connected by a web portion and support a transparent, hollow, cylindrical tube. Graphic material placed adjacent the web portion and within in the tube may be viewed through the tube.
    Type: Grant
    Filed: January 31, 1997
    Date of Patent: April 6, 1999
    Inventor: Kirk Douglas Harrington
  • Patent number: D392329
    Type: Grant
    Filed: January 31, 1997
    Date of Patent: March 17, 1998
    Inventor: Kirk Douglas Harrington